When extreme outliers of plasma NGAL (<0.5th percentile and >99.5th percentile) were excluded, the association between plasma NGAL and the risk of new-onset CKD did not materially change (HR per doubling 1.41 [1.11–1.79], p = 0.005). This evidence concerns the gene LCN2 and chronic kidney disease.